GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-04-14: Form 6-K; Period of report 2021-04-14; Description DIRECTOR/PDMR SHAREHOLDING; Document a4864v.htm.
- 2021-04-14: Form 6-K; Period of report 2021-04-14; Description DIRECTOR/PDMR SHAREHOLDING; Document a4732v.htm.
- 2021-04-12: Form 6-K; Period of report 2021-04-12; Description DIRECTOR/PDMR SHAREHOLDING; Document a2075v.htm.
- 2021-04-12: Form 6-K; Period of report 2021-04-12; Description DIRECTOR/PDMR SHAREHOLDING; Document a1320v.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2021-04-14 | 6-K | 2021-04-14 | DIRECTOR/PDMR SHAREHOLDING | a4864v.htm |
| 2021-04-14 | 6-K | 2021-04-14 | DIRECTOR/PDMR SHAREHOLDING | a4732v.htm |
| 2021-04-12 | 6-K | 2021-04-12 | DIRECTOR/PDMR SHAREHOLDING | a2075v.htm |
| 2021-04-12 | 6-K | 2021-04-12 | DIRECTOR/PDMR SHAREHOLDING | a1320v.htm |
| 2021-04-09 | 6-K | 2021-04-09 | DIRECTOR/PDMR SHAREHOLDING | a0481v.htm |
| 2021-04-09 | 6-K | 2021-04-09 | DIRECTOR/PDMR SHAREHOLDING | a0201v.htm |
| 2021-04-06 | 6-K | 2021-04-06 | DIRECTORATE CHANGE | a5204u.htm |
| 2021-04-01 | 6-K | 2021-04-01 | TOTAL VOTING RIGHTS | a3774u.htm |
| 2021-03-30 | 6-K | 2021-03-30 | PUBLICATION OF 2021 AGM NOTICE | a0167u.htm |
| 2021-03-30 | 6-K | 2021-03-30 | GSK RESPIRATORY PRODUCT SALES REPORTING CHANGES | a9685t.htm |
| 2021-03-24 | 6-K | 2021-03-24 | MONCEF SLAOUI DEPARTS GALVANI BIOELECTRONICS | a3607t.htm |
| 2021-03-23 | 6-K | 2021-03-23 | DIRECTOR/PDMR SHAREHOLDING | a2392t.htm |
| 2021-03-17 | 6-K | 2021-03-17 | CHAIR OF AUDIT & RISK COMMITTEE | a6313s.htm |
| 2021-03-16 | 6-K | 2021-03-16 | MEDICAGO AND GSK START PHASE 3 TRIAL | a4261s.htm |
| 2021-03-15 | 6-K | 2021-03-15 | DIRECTOR/PDMR SHAREHOLDING | a3228s.htm |
| 2021-03-15 | 6-K | 2021-03-15 | ANNUAL REPORT 2020 ON FORM 20-F | a1805s.htm |
| 2021-03-11 | 6-K | 2021-03-11 | DIRECTOR/PDMR SHAREHOLDING | a9974r.htm |
| 2021-03-11 | 6-K | 2021-03-11 | GSK AND VIR SHARE POSITIVE VIR-7831 DATA IN COVID | a8878r.htm |
| 2021-03-10 | 6-K | 2021-03-10 | DIRECTOR/PDMR SHAREHOLDING | a8298r.htm |
| 2021-03-09 | 6-K | 2021-03-09 | ANNUAL FINANCIAL REPORT | a6742r.htm |
| 2021-03-02 | 6-K | 2021-03-02 | DIRECTOR/PDMR SHAREHOLDING | a9120q.htm |
| 2021-03-01 | 6-K | 2021-03-01 | TOTAL VOTING RIGHTS | a6938q.htm |
| 2021-02-25 | 6-K | 2021-02-25 | GSK ANNOUNCES OTILIMAB DATA FOR TREATMENT OF COVID | a3799q.htm |
| 2021-02-24 | 6-K | 2021-02-24 | DIRECTOR/PDMR SHAREHOLDING | a2329q.htm |
| 2021-02-24 | 6-K | 2021-02-24 | HOLDING(S) IN COMPANY | a2219q.htm |
| 2021-02-23 | 6-K | 2021-02-23 | DIRECTOR/PDMR SHAREHOLDING | a0242q.htm |
| 2021-02-22 | 6-K | 2021-02-22 | DIRECTOR/PDMR SHAREHOLDING | a9471p.htm |
| 2021-02-22 | 6-K | 2021-02-22 | SANOFI AND GSK INITIATE NEW PHASE 2 STUDY | a8824p.htm |
| 2021-02-19 | 6-K | 2021-02-19 | DIRECTOR/PDMR SHAREHOLDING | a7686p.htm |
| 2021-02-19 | 6-K | 2021-02-19 | DIRECTOR/PDMR SHAREHOLDING | a7666p.htm |
| 2021-02-19 | 6-K | 2021-02-19 | DIRECTOR/PDMR SHAREHOLDING | a7373p.htm |
| 2021-02-18 | 6-K | 2021-02-18 | DIRECTOR/PDMR SHAREHOLDING | a5792p.htm |
| 2021-02-17 | 6-K | 2021-02-17 | GSK/VIR COLLABORATE ON ANTIBODIES FOR INFLUENZA | a4550p.htm |
| 2021-02-17 | 6-K | 2021-02-17 | DIRECTOR/PDMR SHAREHOLDING | a4085p.htm |
| 2021-02-16 | 6-K | 2021-02-16 | DIRECTOR/PDMR SHAREHOLDING | a0993p.htm |
| 2021-02-16 | 6-K | 2021-02-16 | DIRECTOR/PDMR SHAREHOLDING | a0923p.htm |
| 2021-02-12 | 6-K | 2021-02-12 | DIRECTOR/PDMR SHAREHOLDING | a0051p.htm |
| 2021-02-12 | 6-K | 2021-02-12 | DIRECTOR/PDMR SHAREHOLDING | a0048p.htm |
| 2021-02-12 | 6-K | 2021-02-12 | DIRECTOR/PDMR SHAREHOLDING | a0044p.htm |
| 2021-02-10 | 6-K | 2021-02-10 | DIRECTOR/PDMR SHAREHOLDING | a6827o.htm |
| 2021-02-10 | 6-K | 2021-02-10 | DIRECTOR/PDMR SHAREHOLDING | a6805o.htm |
| 2021-02-04 | 6-K | 2021-02-04 | DIRECTOR/PDMR SHAREHOLDING | a0274o.htm |
| 2021-02-03 | 6-K | 2021-02-03 | FINAL RESULTS | a8915n.htm |
| 2021-02-03 | 6-K | 2021-02-03 | GSK/CUREVAC PARTNER ON NEW MRNA COVID-19 VACCINES | a8348n.htm |
| 2021-02-01 | 6-K | 2021-02-01 | TOTAL VOTING RIGHTS | a5900n.htm |
| 2021-01-26 | 6-K | 2021-01-26 | DIRECTOR/PDMR SHAREHOLDING | a9653m.htm |
| 2021-01-22 | 6-K | 2021-01-22 | FDA APPROVES VIIV HEALTHCARE'S CABENUVA FOR HIV | a5376m.htm |
| 2021-01-20 | 6-K | 2021-01-20 | DIRECTOR/PDMR SHAREHOLDING | a3656m.htm |
| 2021-01-20 | 6-K | 2021-01-20 | DIRECTOR/PDMR SHAREHOLDING | a3652m.htm |
| 2021-01-20 | 6-K | 2021-01-20 | DIRECTOR/PDMR SHAREHOLDING | a3614m.htm |
| 2021-01-19 | 6-K | 2021-01-19 | DIRECTOR/PDMR SHAREHOLDING | a2292m.htm |
| 2021-01-19 | 6-K | 2021-01-19 | DIRECTOR/PDMR SHAREHOLDING | a0886m.htm |
| 2021-01-15 | 6-K | 2021-01-15 | DIRECTOR/PDMR SHAREHOLDING | a9154l.htm |
| 2021-01-15 | 6-K | 2021-01-15 | DIRECTOR/PDMR SHAREHOLDING | a9122l.htm |
| 2021-01-13 | 6-K | 2021-01-13 | DIRECTOR/PDMR SHAREHOLDING | a5864l.htm |
| 2021-01-11 | 6-K | 2021-01-11 | DIRECTOR/PDMR SHAREHOLDING | a2555l.htm |
| 2021-01-11 | 6-K | 2021-01-11 | DIRECTOR/PDMR SHAREHOLDING | a2238l.htm |
| 2021-01-04 | 6-K | 2021-01-04 | TOTAL VOTING RIGHTS | a4502k.htm |